DealReporter sources say Perrigo’s (NYSE:PRGO) sale talks for its RX unit have gone quiet because no bidder has met PRGO’s price expectations.
Only one PE bidder remains, and if the bid isn’t raised, Perrigo could pull the sale offer.
Source: Bloomberg.
PRGO shares are up 0.5% after hours to $43.50.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.